Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.

about

Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.

Item

http://www.wikidata.org/entity/Q42232115

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@en

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@nl

type

Item

label

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@en

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@nl

prefLabel

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@en

Early predictors of antiviral ...... urrent hepatitis C genotype 1.

@nl

P1476

Early predictors of antiviral ...... current hepatitis C genotype 1

@en

P2093

H Allende

http://www.w3.org/2001/XMLSchema#string

J Guardia

http://www.w3.org/2001/XMLSchema#string

J I Esteban

http://www.w3.org/2001/XMLSchema#string

M Bes

http://www.w3.org/2001/XMLSchema#string

M Caralt

http://www.w3.org/2001/XMLSchema#string

R Esteban

http://www.w3.org/2001/XMLSchema#string

S Sauleda

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Histological grading and staging of chronic hepatitis

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.

Preliminary study of two antiviral agents for hepatitis C genotype 1.

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

e118-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ramón Charco

Lluís Castells

Francisco Rodríguez-Frías

M Salcedo

Isabel Campos-Varela

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260754574

http://www.w3.org/2001/XMLSchema#string

P698

24620835

http://www.w3.org/2001/XMLSchema#string